Highlights from GSK Symposia at ERS 2020
INTREPID RESULTS: Investigation of Trelegy Effectiveness: Usual Practice Design.
Speaker: Professor David Halpin is Consultant Physician and Honorary Associate Professor in Respiratory Medicine at the Royal Devon and Exeter Hospital, Exeter, UK
Real World Evidence in COPD - Symposium Recordings
- Devices – The Critical Link Between the Molecule and Treatment
Speaker: Professor Paul Jones PhD, FRCP, FERS. Medical Expert, GSK Emeritus Professor of Respiratory Medicine, St George’s, University of London UK.
- Treatment in the Real World
Speaker: Professor David Halpin is Consultant Physician and Honorary Associate Professor in Respiratory Medicine at the Royal Devon and Exeter Hospital, Exeter, UK.
- Improving symptoms of COPD
Speaker: Professor Francois Maltais, Centre de Pneumologie, Institut Universitaire de Cardiologie et de Pneumologie de Québec, Université Laval, Québec, QC, Canada
COPD Treatment - Symposium Recordings
- Is there a key target in COPD?
Speaker: Professor Alberto Papi, Respiratory Medicine Unit, Department of Medical Sciences, Università di Ferrara, Ferrara, Italy
- Reducing symptoms
Speaker: Professor Claus Vogelmeier, MD, Department of Medicine, Pulmonary and Critical Care Medicine, University Medical Center Giessen and Marburg, Philipps-University Marburg, Germany.
- COPD treatment: targeting mortality
Speaker: Professor MeiLan Han, Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, MI, USA
- Importance of preventing exacerbations
Speaker: Professor Alice M. Turner, University Hospitals Birmingham NHS Foundation Trust, and Institute of Applied Health Research, University of Birmingham, UK